Quark Venture backs SQZ Biotech
SQZ Biotech, which is developing cell therapies to harness the body’s immune system and combat disease, has secured $4 million in funding. The investor is Vancouver-based venture firm Quark Venture Inc. As a result of this investment, SQZ's total funding is now $24 million
2 December 2016•1 min read
